The ability to predict p53 status is of importance, especially in gliomas, since it correlates with the pathological grade, with higher-grade gliomas exhibiting a higher frequency of p53 immuno-positivity/overexpression vs. low-grade gliomas [66]. This evidence concerns the gene TP53 and central nervous system cancer.